The arrival of Irzepatide in the UK is sparking considerable attention, particularly amongst those seeking innovative approaches to weight control. While still relatively recent to the UK market, Irzepatide – a dual GIP and GLP-1 stimulator – is showing effectiveness in helping patients reach long-term weight loss and enhance overall wellbeing.